Others

Glaxosmithkline Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

| Updated on August 01, 2019 Published on August 01, 2019

Dear Sirs,
Subject: Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations
We wish to inform you that pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, the Schedule of Analyst or Institutional Meetings with the Company is as follows
Sr. No Date of Meeting Type of Meeting Name of the Fund/Firm Place of meeting
1. 01-08-2019 Con-Call Reliance Mutual Fund -----
2 08-08-2019 Con-Call Franklin Templeton -----
3 16-09-2019 Group Meeting J P Morgan Mumbai
4 18-09-2019 Group Meeting Citi Group Mumbai
Note: Dates are subject to Changes. Changes may happen due to exigencies on the part of Investors/Company.

Pdf Link: Glaxosmithkline Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Source : BSE - www.bseindia.com

Published on August 01, 2019
This article is closed for comments.
Please Email the Editor